Telmisartan Market is Estimated to Witness High Growth Owing to Opportunities in Hypertension Treatment

 
Telmisartan Market

Telmisartan is an antihypertensive drug used for the treatment of essential hypertension. It acts by selectively blocking the angiotensin II receptors, thereby lowering blood pressure. Telmisartan has shown better control of blood pressure with fewer side effects compared to other anti-hypertensive drugs, and can be used as monotherapy or in combination therapy.

The global telmisartan market is estimated to be valued at US$ 4109.53 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The growing prevalence of hypertension across the world presents a major opportunity for the telmisartan market. As per the World Health Organization, hypertension affects over 1.13 billion people globally, with two-thirds of hypertension cases reported in developing nations. High blood pressure is a primary risk factor for cardiovascular and kidney diseases. The increasing awareness regarding management of hypertension and benefits of controlling blood pressure are encouraging more people to opt for treatment. Telmisartan has emerged as an effective therapy for hypertension due to its high efficacy and tolerability. The expanding patient pool of hypertension worldwide will likely drive significant demand for telmisartan over the forecast period.

Porter’s Analysis
Threat of new entrants: The telmisartan market is consolidated with the presence of large players operating globally, making it difficult for new players to enter the market. However, it has moderate profit potential due to patent expirations of major drugs.

Bargaining power of buyers: The bargaining power of buyers is moderate as telmisartan has few substitutes available for the treatment of hypertension. However, buyers can negotiate on price by increasing volume purchases.

Bargaining power of suppliers: The bargaining power of suppliers is low due to the availability of substitutable raw materials supplied by various vendors globally. Supplier switching costs are also low.

Threat of new substitutes: The threat of new substitutes is moderate as there are a few drug alternatives and substitutes available for telmisartan in the management of hypertension.

Competitive rivalry: The competitive rivalry is high owing to the presence of global and domestic players offering generic versions after major drugs lose exclusivity. Players compete on price and product differentiation.

SWOT Analysis
Strengths: High usage in hypertension therapy, long patent protection expired, availability of low-cost generics.
Weaknesses: High R&D costs, stringent regulations for approval.
Opportunities: Growth in emerging markets, focus on fixed dose combinations.
Threats: Patent expiries of blockbuster drugs, regulatory hurdles.

Key Takeaways
The Global Telmisartan Market Demand is expected to witness high growth over the forecast period owing to the increasing prevalence of hypertension worldwide. The global Telmisartan Market is estimated to be valued at US$ 4109.53 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.

The Asia Pacific region currently dominates the market and is expected to grow at the fastest rate due to the large patient pool and rising healthcare expenditures in countries like China and India.

Key players operating in the telmisartan market are Global Self Storage Inc., U-Haul International Inc. (Amerco), Urban Self Storage Inc., Life Storage Inc., Amsdell Cos./Compass Self Storage, CubeSmart LP, All Storage, National Storage Affiliates Trust, National Storage REIT, Safestore Holdings PLC, (Great Value Storage) World Class Capital Group LLC, Simply Self Storage Management LLC, SmartStop Asset Management LLC, StorageMart, Metro Storage LLC, Prime Storage Group, and W. P. Carey Inc. Regional analysis focuses on increasing production of generics in Asia and strategy of manufacturers to strengthen presence.

For more details on the report, Read-https://www.ukwebwire.com/telmisartan-market-growth-market-size-share-analysis/

Comments

Post a Comment

Popular posts from this blog

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more